 |
InterPro: IPR012317 Poly(ADP-ribose) polymerase, catalytic domain
Protein matches
|
UniProtKB Matches: 655 proteins |
|
Accession
|
IPR012317 Poly(ADP-ribose)pol_cat_dom |
Secondary
|
IPR001290
|
Type
|
Domain |
Signatures
|
|
InterPro Relationships
|
|
Found in
|
IPR008288 NAD+ ADP-ribosyltransferase
|
GO Term annotation
|
|
Function
|
GO:0003950 NAD+ ADP-ribosyltransferase activity
|
|
InterPro annotation
|
|
Entry Details in BioMart
|
Abstract
|
Poly(ADP-ribose) polymerases (PARP) are a family of enzymes
present in eukaryotes, which catalyze the poly(ADP-ribosyl)ation of a limited
number of proteins involved in chromatin architecture, DNA repair, or in DNA
metabolism, including PARP itself. PARP, also known as poly(ADP-ribose)
synthetase and poly(ADP-ribose) transferase, transfers the ADP-ribose moiety
from its substrate, nicotinamide adenine dinucleotide (NAD), to carboxylate
groups of aspartic and glutamic residues. Whereas some PARPs might function in
genome protection, others appear to play different roles in the cell,
including telomere replication and cellular transport. PARP-1 is a
multifunctional enzyme. The polypeptide has a highly conserved modular
organization consisting of an N-terminal DNA-binding domain, a central
regulating segment, and a C-terminal or F region accommodating the catalytic
centre. The F region is composed of two parts: a purely alpha-helical N-
terminal domain (alpha-hd), and the mixed alpha/beta C-terminal catalytic
domain bearing the putative NAD binding site. Although proteins of the PARP
family are related through their PARP catalytic domain, they do not resemble
each other outside of that region, but rather, they contain unique domains
that distinguish them from each other and hint at their discrete functions.
Domains with which the PARP catalytic domain is found associated include
zinc fingers, SAP, ankyrin, BRCT, Macro, SAM, WWE and UIM domains [1, 2, 3].
The alpha-hd domain is about 130 amino acids in length and consists of an up-up-down-up-down-down motif of helices. It is
thought to relay the activation signal issued on binding to damaged DNA [4, 5].
The PARP catalytic domain is about 230 residues in length. Its core consists of a five-stranded antiparallel beta-sheet and
four-stranded mixed beta-sheet. The two sheets are consecutive and are
connected via a single pair of hydrogen bonds between two strands that run at
an angle of 90 degrees. These central beta-sheets are surrounded by five alpha-helices, three 3(10)-helices, and by a three- and a two-stranded beta-sheet in
a 37-residue excursion between two central beta-strands [4, 5]. The active
site, known as the 'PARP signature' is formed by a block of 50 amino acids
that is strictly conserved among the vertebrates and
highly conserved among all species. The 'PARP signature' is characteristic of
all PARP protein family members. It is formed by a segment of conserved amino
acid residues formed by a beta-sheet, an alpha-helix, a 3(10)-helix, a beta-sheet, and an alpha-helix [3].
|
Structural links
|
|
Database links
|
Pfam Clan: CL0084.9
|
Interactions
|
This domain has been experimentally proven to be involved in Protein:Protein interactions. Representative
data is shown with the following
example proteins:
|
Publications
|
|
1.
|
de Murcia G, Menissier de Murcia J.
Poly(ADP-ribose) polymerase: a molecular nick-sensor.
Trends Biochem. Sci. 19 172-6 1994
[PubMed: 8016868]
http://dx.doi.org/10.1016/0968-0004(94)90280-1
|
|
2.
|
Ame JC, Spenlehauer C, de Murcia G.
The PARP superfamily.
Bioessays 26 882-93 2004
[PubMed: 15273990]
http://dx.doi.org/10.1002/bies.20085
|
|
3.
|
Nguewa PA, Fuertes MA, Valladares B, Alonso C, Perez JM.
Poly(ADP-ribose) polymerases: homology, structural domains and functions. Novel therapeutical applications.
Prog. Biophys. Mol. Biol. 88 143-72 2005
[PubMed: 15561303]
http://dx.doi.org/10.1016/j.pbiomolbio.2004.01.001
|
|
4.
|
Ruf A, Mennissier de Murcia J, de Murcia G, Schulz GE.
Structure of the catalytic fragment of poly(AD-ribose) polymerase from chicken.
Proc. Natl. Acad. Sci. U.S.A. 93 7481-5 1996
[PubMed: 8755499]
http://dx.doi.org/10.1073/pnas.93.15.7481
|
|
5.
|
Oliver AW, Ame JC, Roe SM, Good V, de Murcia G, Pearl LH.
Crystal structure of the catalytic fragment of murine poly(ADP-ribose) polymerase-2.
Nucleic Acids Res. 32 456-64 2004
[PubMed: 14739238]
http://dx.doi.org/10.1093/nar/gkh215
|
Additional Reading
|
|
Simonin F, Hofferer L, Panzeter PL, Muller S, de Murcia G, Althaus FR.
The carboxyl-terminal domain of human poly(ADP-ribose) polymerase. Overproduction in Escherichia coli, large scale purification, and characterization.
J. Biol. Chem. 268 1993 13454-61
[PubMed: 8390463]
http://intl.jbc.org/cgi/content/abstract/268/18/13454
|
|
Jaspers P, Blomster T, Brosche M, Salojarvi J, Ahlfors R, Vainonen JP, Reddy RA, Immink R, Angenent G, Turck F, Overmyer K, Kangasjarvi J.
Unequally redundant RCD1 and SRO1 mediate stress and developmental responses and interact with transcription factors.
Plant J. 2009
[PubMed: 19548978]
|
|
Hattori K, Kido Y, Yamamoto H, Ishida J, Kamijo K, Murano K, Ohkubo M, Kinoshita T, Iwashita A, Mihara K, Yamazaki S, Matsuoka N, Teramura Y, Miyake H.
Rational approaches to discovery of orally active and brain-penetrable quinazolinone inhibitors of poly(ADP-ribose)polymerase.
J. Med. Chem. 47 2004 4151-4
[PubMed: 15293985]
http://dx.doi.org/10.1021/jm0499256
|
|
Ruf A, de Murcia G, Schulz GE.
Inhibitor and NAD+ binding to poly(ADP-ribose) polymerase as derived from crystal structures and homology modeling.
Biochemistry 37 1998 3893-900
[PubMed: 9521710]
http://dx.doi.org/10.1021/bi972383s
|
|
Iwashita A, Hattori K, Yamamoto H, Ishida J, Kido Y, Kamijo K, Murano K, Miyake H, Kinoshita T, Warizaya M, Ohkubo M, Matsuoka N, Mutoh S.
Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP-ribose) polymerase-1/2 inhibitors.
FEBS Lett. 579 2005 1389-93
[PubMed: 15733846]
http://dx.doi.org/10.1016/j.febslet.2005.01.036
|
|
Kinoshita T, Nakanishi I, Warizaya M, Iwashita A, Kido Y, Hattori K, Fujii T.
Inhibitor-induced structural change of the active site of human poly(ADP-ribose) polymerase.
FEBS Lett. 556 2004 43-6
[PubMed: 14706823]
http://dx.doi.org/10.1016/S0014-5793(03)01362-0
|
|
White AW, Almassy R, Calvert AH, Curtin NJ, Griffin RJ, Hostomsky Z, Maegley K, Newell DR, Srinivasan S, Golding BT.
Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase.
J. Med. Chem. 43 2000 4084-97
[PubMed: 11063605]
http://dx.doi.org/10.1021/jm000950v
|
|